nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—CYP1A2—Carmustine—malignant glioma	0.262	1	CbGbCtD
Tocainide—SCN8A—cerebellar cortex—malignant glioma	0.103	0.232	CbGeAlD
Tocainide—SCN8A—brainstem—malignant glioma	0.0162	0.0364	CbGeAlD
Tocainide—SCN8A—telencephalon—malignant glioma	0.0144	0.0323	CbGeAlD
Tocainide—Mexiletine—CYP2B6—malignant glioma	0.0141	0.379	CrCbGaD
Tocainide—SCN11A—spinal cord—malignant glioma	0.0133	0.0299	CbGeAlD
Tocainide—SCN1A—brainstem—malignant glioma	0.0122	0.0275	CbGeAlD
Tocainide—SCN2A—brainstem—malignant glioma	0.0112	0.0253	CbGeAlD
Tocainide—SCN1A—telencephalon—malignant glioma	0.0109	0.0244	CbGeAlD
Tocainide—SCN11A—central nervous system—malignant glioma	0.0108	0.0243	CbGeAlD
Tocainide—SCN8A—spinal cord—malignant glioma	0.0101	0.0227	CbGeAlD
Tocainide—SCN2A—telencephalon—malignant glioma	0.00997	0.0224	CbGeAlD
Tocainide—SCN10A—telencephalon—malignant glioma	0.00962	0.0216	CbGeAlD
Tocainide—SCN9A—midbrain—malignant glioma	0.00907	0.0204	CbGeAlD
Tocainide—SCN9A—spinal cord—malignant glioma	0.00885	0.0199	CbGeAlD
Tocainide—SCN3A—telencephalon—malignant glioma	0.00877	0.0197	CbGeAlD
Tocainide—SCN11A—brain—malignant glioma	0.00856	0.0193	CbGeAlD
Tocainide—SCN1A—medulla oblongata—malignant glioma	0.00854	0.0192	CbGeAlD
Tocainide—SCN8A—central nervous system—malignant glioma	0.00817	0.0184	CbGeAlD
Tocainide—SCN8A—cerebellum—malignant glioma	0.00799	0.018	CbGeAlD
Tocainide—SCN2A—medulla oblongata—malignant glioma	0.00784	0.0176	CbGeAlD
Tocainide—SCN1A—midbrain—malignant glioma	0.0078	0.0176	CbGeAlD
Tocainide—SCN1A—spinal cord—malignant glioma	0.00761	0.0171	CbGeAlD
Tocainide—SCN7A—brain—malignant glioma	0.00728	0.0164	CbGeAlD
Tocainide—SCN2A—midbrain—malignant glioma	0.00716	0.0161	CbGeAlD
Tocainide—SCN2A—spinal cord—malignant glioma	0.00699	0.0157	CbGeAlD
Tocainide—SCN3A—medulla oblongata—malignant glioma	0.00689	0.0155	CbGeAlD
Tocainide—SCN10A—spinal cord—malignant glioma	0.00674	0.0152	CbGeAlD
Tocainide—Ropivacaine—CYP2B6—malignant glioma	0.00667	0.179	CrCbGaD
Tocainide—Lidocaine—CYP2C18—malignant glioma	0.00653	0.175	CrCbGaD
Tocainide—SCN8A—brain—malignant glioma	0.00649	0.0146	CbGeAlD
Tocainide—SCN4A—central nervous system—malignant glioma	0.00641	0.0144	CbGeAlD
Tocainide—SCN3A—midbrain—malignant glioma	0.00629	0.0142	CbGeAlD
Tocainide—SCN1A—central nervous system—malignant glioma	0.00618	0.0139	CbGeAlD
Tocainide—SCN3A—spinal cord—malignant glioma	0.00614	0.0138	CbGeAlD
Tocainide—SCN1A—cerebellum—malignant glioma	0.00604	0.0136	CbGeAlD
Tocainide—SCN9A—brain—malignant glioma	0.0057	0.0128	CbGeAlD
Tocainide—SCN2A—central nervous system—malignant glioma	0.00567	0.0128	CbGeAlD
Tocainide—SCN2A—cerebellum—malignant glioma	0.00554	0.0125	CbGeAlD
Tocainide—SCN10A—central nervous system—malignant glioma	0.00547	0.0123	CbGeAlD
Tocainide—Lidocaine—EGFR—malignant glioma	0.0051	0.137	CrCbGaD
Tocainide—SCN4A—brain—malignant glioma	0.00509	0.0114	CbGeAlD
Tocainide—SCN3A—central nervous system—malignant glioma	0.00498	0.0112	CbGeAlD
Tocainide—SCN5A—central nervous system—malignant glioma	0.00497	0.0112	CbGeAlD
Tocainide—SCN1A—brain—malignant glioma	0.0049	0.011	CbGeAlD
Tocainide—SCN3A—cerebellum—malignant glioma	0.00487	0.011	CbGeAlD
Tocainide—Lidocaine—CYP2B6—malignant glioma	0.00485	0.13	CrCbGaD
Tocainide—SCN2A—brain—malignant glioma	0.0045	0.0101	CbGeAlD
Tocainide—SCN10A—brain—malignant glioma	0.00434	0.00976	CbGeAlD
Tocainide—SCN3A—brain—malignant glioma	0.00396	0.0089	CbGeAlD
Tocainide—SCN5A—brain—malignant glioma	0.00394	0.00887	CbGeAlD
Tocainide—ALB—brain—malignant glioma	0.00316	0.0071	CbGeAlD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000264	0.00103	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	0.000264	0.00103	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—KRAS—malignant glioma	0.000264	0.00103	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—VEGFA—malignant glioma	0.000263	0.00103	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—VEGFA—malignant glioma	0.000263	0.00103	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000259	0.00101	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—EGFR—malignant glioma	0.000258	0.00101	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—RAF1—malignant glioma	0.000257	0.001	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—FGF2—malignant glioma	0.000255	0.000995	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—FGF2—malignant glioma	0.000255	0.000995	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—ERBB2—malignant glioma	0.000254	0.000991	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—VEGFA—malignant glioma	0.000254	0.000991	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—VEGFA—malignant glioma	0.000254	0.000991	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	0.000253	0.000988	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	0.000253	0.000987	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—VEGFA—malignant glioma	0.000253	0.000987	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—STAT3—malignant glioma	0.00025	0.000977	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—EGFR—malignant glioma	0.000249	0.000971	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000247	0.000965	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—EGFR—malignant glioma	0.000247	0.000963	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—RAF1—malignant glioma	0.000247	0.000962	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—RAF1—malignant glioma	0.000247	0.000962	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—FGFR1—malignant glioma	0.000246	0.000958	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000244	0.000953	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—ERBB2—malignant glioma	0.000244	0.000952	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—ERBB2—malignant glioma	0.000244	0.000952	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—KRAS—malignant glioma	0.000244	0.000951	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000243	0.000946	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—RAF1—malignant glioma	0.000238	0.000928	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—RAF1—malignant glioma	0.000238	0.000928	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—EGFR—malignant glioma	0.000237	0.000925	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—EGFR—malignant glioma	0.000237	0.000925	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—TNF—malignant glioma	0.000237	0.000925	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—ERBB2—malignant glioma	0.000235	0.000918	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—ERBB2—malignant glioma	0.000235	0.000918	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—KRAS—malignant glioma	0.000235	0.000917	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—RAF1—malignant glioma	0.000234	0.000914	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—KRAS—malignant glioma	0.000233	0.000909	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000233	0.000907	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—ERBB2—malignant glioma	0.000232	0.000904	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—KDR—malignant glioma	0.000231	0.000902	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ANGPT2—malignant glioma	0.000231	0.000902	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00023	0.000896	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—EGFR—malignant glioma	0.000229	0.000892	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—EGFR—malignant glioma	0.000229	0.000892	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MMP9—malignant glioma	0.000228	0.000889	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—EGFR—malignant glioma	0.000228	0.000888	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MET—malignant glioma	0.000226	0.000883	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000226	0.00088	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000225	0.000876	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—KRAS—malignant glioma	0.000224	0.000874	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—KRAS—malignant glioma	0.000224	0.000874	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.000218	0.00085	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MMP9—malignant glioma	0.000218	0.00085	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—TNF—malignant glioma	0.000217	0.000846	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—KRAS—malignant glioma	0.000216	0.000842	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—KRAS—malignant glioma	0.000216	0.000842	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—KRAS—malignant glioma	0.000215	0.000839	CbGpPWpGaD
Tocainide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000212	0.000828	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000211	0.000823	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MMP9—malignant glioma	0.000209	0.000817	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MMP9—malignant glioma	0.000209	0.000817	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.000209	0.000817	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000207	0.000806	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000206	0.000804	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TNF—malignant glioma	0.000206	0.000804	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000206	0.000802	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—VEGFA—malignant glioma	0.000205	0.000798	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—STAT3—malignant glioma	0.000203	0.00079	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000202	0.000788	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000202	0.000788	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MMP9—malignant glioma	0.000202	0.000787	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MMP9—malignant glioma	0.000202	0.000787	CbGpPWpGaD
Tocainide—ALB—Hemostasis—HIST1H3B—malignant glioma	0.0002	0.000781	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MMP9—malignant glioma	0.000199	0.000776	CbGpPWpGaD
Tocainide—ALB—Hemostasis—MYB—malignant glioma	0.000198	0.000774	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—AKT1—malignant glioma	0.000198	0.000772	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000198	0.000772	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000196	0.000766	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—VEGFA—malignant glioma	0.000196	0.000763	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT2—malignant glioma	0.000195	0.000761	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—STAT3—malignant glioma	0.000194	0.000756	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000194	0.000756	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000192	0.000751	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000192	0.000751	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000192	0.000747	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000192	0.000747	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000191	0.000745	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000189	0.000737	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000189	0.000737	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—VEGFA—malignant glioma	0.000188	0.000733	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—VEGFA—malignant glioma	0.000188	0.000733	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—STAT3—malignant glioma	0.000186	0.000726	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—STAT3—malignant glioma	0.000186	0.000726	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—EGFR—malignant glioma	0.000184	0.000718	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TP53—malignant glioma	0.000182	0.000709	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—VEGFA—malignant glioma	0.000181	0.000707	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—VEGFA—malignant glioma	0.000181	0.000707	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—STAT3—malignant glioma	0.00018	0.0007	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—STAT3—malignant glioma	0.00018	0.0007	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000179	0.0007	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000179	0.000697	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000177	0.000691	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—AKT1—malignant glioma	0.000176	0.000688	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—EGFR—malignant glioma	0.000176	0.000687	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TNF—malignant glioma	0.000175	0.000684	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—KRAS—malignant glioma	0.000174	0.000678	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—EGFR—malignant glioma	0.000169	0.00066	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—EGFR—malignant glioma	0.000169	0.00066	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TNF—malignant glioma	0.000168	0.000654	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—RAF1—malignant glioma	0.000167	0.000652	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—KRAS—malignant glioma	0.000166	0.000649	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—ERBB2—malignant glioma	0.000165	0.000645	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000164	0.000639	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—EGFR—malignant glioma	0.000163	0.000636	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—EGFR—malignant glioma	0.000163	0.000636	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—AKT1—malignant glioma	0.000161	0.00063	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TNF—malignant glioma	0.000161	0.000628	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TNF—malignant glioma	0.000161	0.000628	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—EGFR—malignant glioma	0.000161	0.000627	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.00016	0.000623	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.00016	0.000623	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—KRAS—malignant glioma	0.00016	0.000623	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—KRAS—malignant glioma	0.00016	0.000623	CbGpPWpGaD
Tocainide—ALB—Metabolism—COX8A—malignant glioma	0.000159	0.000621	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TNF—malignant glioma	0.000155	0.000606	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TNF—malignant glioma	0.000155	0.000606	CbGpPWpGaD
Tocainide—ALB—Hemostasis—H3F3A—malignant glioma	0.000155	0.000603	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—KRAS—malignant glioma	0.000154	0.000601	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—KRAS—malignant glioma	0.000154	0.000601	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000153	0.000597	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—KRAS—malignant glioma	0.000152	0.000592	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000151	0.00059	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000142	0.000555	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MMP9—malignant glioma	0.000142	0.000554	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.00014	0.000546	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000138	0.00054	CbGpPWpGaD
Tocainide—ALB—Metabolism—ASMT—malignant glioma	0.000135	0.000528	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000135	0.000527	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000134	0.000525	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000134	0.000523	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000132	0.000516	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—AKT1—malignant glioma	0.000131	0.000509	CbGpPWpGaD
Tocainide—ALB—Hemostasis—KNG1—malignant glioma	0.000127	0.000497	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—malignant glioma	0.000127	0.000497	CbGpPWpGaD
Tocainide—ALB—Metabolism—BCAN—malignant glioma	0.000127	0.000496	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—STAT3—malignant glioma	0.000126	0.000492	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IFNA2—malignant glioma	0.000125	0.000487	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—AKT1—malignant glioma	0.000125	0.000487	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000124	0.000484	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.00012	0.000468	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—AKT1—malignant glioma	0.00012	0.000468	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—AKT1—malignant glioma	0.00012	0.000468	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SOD1—malignant glioma	0.000118	0.000462	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000118	0.000461	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000117	0.000457	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—AKT1—malignant glioma	0.000116	0.000451	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—AKT1—malignant glioma	0.000116	0.000451	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—EGFR—malignant glioma	0.000115	0.000447	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—COX8A—malignant glioma	0.000111	0.000434	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TNF—malignant glioma	0.000109	0.000426	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PTK2—malignant glioma	0.000109	0.000424	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—KRAS—malignant glioma	0.000108	0.000423	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000108	0.00042	CbGpPWpGaD
Tocainide—ALB—Metabolism—IDH2—malignant glioma	0.000103	0.0004	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.95e-05	0.000388	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.67e-05	0.000377	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP2B6—malignant glioma	9.64e-05	0.000376	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ASMT—malignant glioma	9.46e-05	0.000369	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.25e-05	0.000361	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	9.15e-05	0.000357	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PDGFB—malignant glioma	9.13e-05	0.000356	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—BCAN—malignant glioma	8.9e-05	0.000347	CbGpPWpGaD
Tocainide—ALB—Metabolism—IDH1—malignant glioma	8.82e-05	0.000344	CbGpPWpGaD
Tocainide—ALB—Hemostasis—CAV1—malignant glioma	8.66e-05	0.000338	CbGpPWpGaD
Tocainide—ALB—Metabolism—SPHK1—malignant glioma	8.53e-05	0.000333	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP2C18—malignant glioma	8.36e-05	0.000326	CbGpPWpGaD
Tocainide—ALB—Hemostasis—F2—malignant glioma	8.24e-05	0.000321	CbGpPWpGaD
Tocainide—ALB—Hemostasis—FN1—malignant glioma	8.24e-05	0.000321	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT1—malignant glioma	8.13e-05	0.000317	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3CG—malignant glioma	7.89e-05	0.000308	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.88e-05	0.000307	CbGpPWpGaD
Tocainide—ALB—Hemostasis—EGF—malignant glioma	7.79e-05	0.000304	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PTPN11—malignant glioma	7.75e-05	0.000302	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT2—malignant glioma	7.21e-05	0.000281	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.18e-05	0.00028	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—IDH2—malignant glioma	7.17e-05	0.00028	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	7.15e-05	0.000279	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3CD—malignant glioma	6.93e-05	0.00027	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.93e-05	0.00027	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.76e-05	0.000264	CbGpPWpGaD
Tocainide—ALB—Metabolism—GSTT1—malignant glioma	6.76e-05	0.000264	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP2B6—malignant glioma	6.74e-05	0.000263	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS1—malignant glioma	6.33e-05	0.000247	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.31e-05	0.000246	CbGpPWpGaD
Tocainide—ALB—Hemostasis—RAF1—malignant glioma	6.19e-05	0.000241	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—IDH1—malignant glioma	6.17e-05	0.000241	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3CB—malignant glioma	6.04e-05	0.000236	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SPHK1—malignant glioma	5.97e-05	0.000233	CbGpPWpGaD
Tocainide—ALB—Metabolism—BCHE—malignant glioma	5.89e-05	0.00023	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP2C18—malignant glioma	5.85e-05	0.000228	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	5.84e-05	0.000228	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC5A5—malignant glioma	5.82e-05	0.000227	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IL2—malignant glioma	5.55e-05	0.000216	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.51e-05	0.000215	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.5e-05	0.000215	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.45e-05	0.000213	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	5.36e-05	0.000209	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.02e-05	0.000196	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.85e-05	0.000189	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.75e-05	0.000185	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GSTT1—malignant glioma	4.73e-05	0.000184	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—malignant glioma	4.72e-05	0.000184	CbGpPWpGaD
Tocainide—ALB—Metabolism—GSTP1—malignant glioma	4.69e-05	0.000183	CbGpPWpGaD
Tocainide—ALB—Metabolism—CAT—malignant glioma	4.56e-05	0.000178	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS1—malignant glioma	4.43e-05	0.000173	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.41e-05	0.000172	CbGpPWpGaD
Tocainide—ALB—Metabolism—NCOR1—malignant glioma	4.31e-05	0.000168	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—BCHE—malignant glioma	4.12e-05	0.000161	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.07e-05	0.000159	CbGpPWpGaD
Tocainide—ALB—Hemostasis—KRAS—malignant glioma	4.01e-05	0.000156	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.85e-05	0.00015	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.81e-05	0.000149	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3CA—malignant glioma	3.68e-05	0.000144	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TP53—malignant glioma	3.56e-05	0.000139	CbGpPWpGaD
Tocainide—ALB—Metabolism—CAV1—malignant glioma	3.51e-05	0.000137	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.35e-05	0.000131	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.32e-05	0.00013	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GSTP1—malignant glioma	3.28e-05	0.000128	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3CG—malignant glioma	3.2e-05	0.000125	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CAT—malignant glioma	3.19e-05	0.000124	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPARG—malignant glioma	3.09e-05	0.00012	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NCOR1—malignant glioma	3.01e-05	0.000117	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT1—malignant glioma	3.01e-05	0.000117	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3CD—malignant glioma	2.81e-05	0.00011	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CAV1—malignant glioma	2.45e-05	9.58e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3CB—malignant glioma	2.45e-05	9.55e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—malignant glioma	2.43e-05	9.47e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.35e-05	9.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.24e-05	8.72e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPARG—malignant glioma	2.16e-05	8.42e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTEN—malignant glioma	2.12e-05	8.26e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.97e-05	7.67e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.71e-05	6.68e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—malignant glioma	1.7e-05	6.62e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3CA—malignant glioma	1.49e-05	5.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTEN—malignant glioma	1.48e-05	5.78e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKT1—malignant glioma	1.22e-05	4.76e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.04e-05	4.07e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKT1—malignant glioma	8.53e-06	3.33e-05	CbGpPWpGaD
